Results for technologies (3)
Advanced filter
Cell-free microRNA as a Prognostic Biomarker for Amyotrophic Lateral Sclerosis (ALS) (No. T4-2038)
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder of the human motor neuron system, for which no effective treatment exists.
ALS is a relentless neurodegenerative syndrome of the human motor neuron system, for which no curative treatment exists. It is...
Read more
6115
Frontotemporal Dementia Diagnosis Using Circulating microRNA Biomarkers (No. T4-2037)
Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder characterized by frontal and temporal lobe atrophy, typically manifesting with behavioral or language impairment.
FTD is the second most common form of dementia, after Alzheimer’s disease below the age o...
Read more
6082
Repurposing of a Small Molecule Drug for ALS Treatment (No. T4-1632)
Amyotrophic Lateral Sclerosis (ALS) remains an incurable neurodegenerative disease, in need of innovative treatment options. Prof. Eran Hornstein and his team identified microRNAs (miRNA) as pivotal regulators of ALS progression.
ALS is a progressive neurodegenerative disorder cau...
Read more
18887